SCHEMBL15020023

SCHEMBL15020023

CCCCCCCOc1ccc(C2(O)CCN(C(=O)O)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.53
DRD4 P21917 1/20 0.53
DRD3 P35462 1/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ALDH1A1 P00352 2/20 0.53
LMNA P02545 1/20 0.53
TP53 P04637 1/20 0.51
TSHR P16473 1/20 0.51
PLA2G4B P0C869 1/20 0.50
RARB P10826 3/20 0.48
S1PR5 Q9H228 4/20 0.47
HRH3 Q9Y5N1 3/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
S1PR1 P21453 3/20 0.46
S1PR3 Q99500 2/20 0.46
THRA P10827 1/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538473 0.85 GPR119 (0.52) DRD2DRD4DRD3MEN1KMT2A
SCHEMBL15019539 0.85 GPR119 (0.52) DRD2DRD4DRD3MEN1KMT2A
SCHEMBL22384186 0.84 MEN1 (0.57) DRD2DRD4DRD3MEN1KMT2A
SCHEMBL6538566 0.84 DRD2 (0.51) DRD2DRD4DRD3MEN1KMT2A
SCHEMBL1581964 0.82 KMT2A (0.52) MEN1KMT2AALDH1A1LMNATP53
SCHEMBL6538579 0.82 TSHR (0.61) DRD2DRD4DRD3MEN1KMT2A
SCHEMBL9797621 0.80 S1PR5 (0.59) MEN1KMT2ATP53TSHRPLA2G4B
SCHEMBL9798083 0.80 S1PR5 (0.59) MEN1KMT2ATP53TSHRPLA2G4B
SCHEMBL9798260 0.80 S1PR5 (0.59) MEN1KMT2ATP53TSHRPLA2G4B
SCHEMBL9798246 0.79 S1PR5 (0.57) MEN1KMT2ATP53TSHRPLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008056-A1 NOVEL GLP-1 RECEPTOR MODULATORS Receptos, Inc. (US) 2016-04-20 EP disclosed
WO-2014201172-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS, INC. (US) 2014-12-18 WO disclosed
EP-2791112-A2 CARBOXYLIC ACID DERIVATIVES COMPRISING FOUR CYCLES ACTING AS GLP-1 RECEPTOR MODULATORS FOR THERAPY OF DISEASES SUCH AS DIABETES Receptos, Inc. (US) 2014-10-22 EP disclosed
WO-2013090454-A2 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS, INC. (US) 2013-06-20 WO disclosed